Compounds > naltrexone

naltrexone and Opiate Overdose

naltrexone has been researched along with Opiate Overdose in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	10 (100.00)	2.80

Authors

Authors	Studies
Allen, LR; Manini, AF; Nobel, I; Richardson, LD; Shastry, S; Vidal, K	1
Domino, ME; Grove, LR; Rao, N	1
Cox, KM; Doyle, M; Marsch, LA; McLeman, BM; Murray, OB; Ryer, J; Saunders, EC; Watts, D	1
Barnett, ML; Chyn, D; Hardy, B; Huskamp, HA; Lewinson, T; Meara, E; Mehrotra, A; Morden, NE; Onsando, M	1
Amlung, J; Lowder, EM; Ray, BR	1
Dionne, R; Fishman, M; Lertch, E; Ludwig, A; Mitchell, SG; Monico, LB; Schwartz, RP	1
Akerman, SC; Bloomgren, G; Desai, A; Fratantonio, J; Jain, P; Liles-Burden, MA; Marino, R; McKinnell, K; Sullivan, MA; Vunnava, P; Wenten, M	1
Board, A; Guy, GP; Jones, CM	1

Trials

1 trial(s) available for naltrexone and Opiate Overdose

Article	Year
Opioid overdose experiences in a sample of US adolescents and young adults: a thematic analysis. Addiction (Abingdon, England), 2021, Volume: 116, Issue:4 Topics: Adolescent; Analgesics, Opioid; Drug Overdose; Humans; Naltrexone; Narcotic Antagonists; Opiate Overdose; Opioid-Related Disorders; United States; Young Adult	2021

Other Studies

9 other study(ies) available for naltrexone and Opiate Overdose

Article	Year
Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity. The American journal of emergency medicine, 2022, Volume: 51 Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Hospital Mortality; Humans; Length of Stay; Logistic Models; Male; Methadone; Middle Aged; Naltrexone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Prospective Studies	2022
Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries? Addiction (Abingdon, England), 2022, Volume: 117, Issue:11 Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Medicaid; Naltrexone; North Carolina; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; United States	2022
Nalmefene returns for reversal of opioid overdose. The Medical letter on drugs and therapeutics, 2022, 09-05, Volume: 64, Issue:1658 Topics: Humans; Naltrexone; Narcotic Antagonists; Opiate Overdose	2022
Augmenting project ECHO for opioid use disorder with data-informed quality improvement. Addiction science & clinical practice, 2023, 04-28, Volume: 18, Issue:1 Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Quality Improvement; Surveys and Questionnaires	2023
Racial Inequality in Receipt of Medications for Opioid Use Disorder. The New England journal of medicine, 2023, May-11, Volume: 388, Issue:19 Topics: Aged; Analgesics, Opioid; Benzodiazepines; Black or African American; Buprenorphine; Healthcare Disparities; Hispanic or Latino; Humans; Medicare; Naloxone; Naltrexone; Narcotic Antagonists; Opiate Overdose; Opioid-Related Disorders; United States; White	2023
Nalmefene nasal spray (Opvee) for reversal of opioid overdose. The Medical letter on drugs and therapeutics, 2023, 10-16, Volume: 65, Issue:1687 Topics: Analgesics, Opioid; Drug Overdose; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Nasal Sprays; Opiate Overdose	2023
Individual and county-level variation in outcomes following non-fatal opioid-involved overdose. Journal of epidemiology and community health, 2020, Volume: 74, Issue:4 Topics: Adult; Analgesics, Opioid; Black or African American; Black People; Cohort Studies; Emergency Medical Services; Ethnicity; Female; Humans; Indiana; Local Government; Male; Middle Aged; Multilevel Analysis; Naltrexone; Narcotic Antagonists; Opiate Overdose; Opioid-Related Disorders; White People	2020
Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018. Drug safety, 2021, Volume: 44, Issue:3 Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Tolerance; Humans; Injections, Intramuscular; Naltrexone; Narcotic Antagonists; Opiate Overdose; Opioid-Related Disorders	2021
Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020. Drug and alcohol dependence, 2021, 02-01, Volume: 219 Topics: Analgesics, Opioid; Angiotensin Receptor Antagonists; Antidepressive Agents; Benzodiazepines; Buprenorphine; COVID-19; Drug Utilization; Forecasting; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Naloxone; Naltrexone; Opiate Overdose; Opioid-Related Disorders; Pandemics; SARS-CoV-2; United States	2021